Furthermore, a pronounced up-regulation of SPAG5 was observed in the lungs of patients with an active fibrotic process [83], TOP2A was found to occupy a hub position in the severe COVID-19 regulome [84], and its inhibitors were predicted by an artificial intelligence approach as promising candidates for the treatment of critically ill COVID-19 patients [85]. The gene discussed is SPAG5; the disease is COVID-19.